Zero Suicide: What about “Treat”?

Date: May 3, 2024

In this Crisis-The Journal of Crisis Intervention and Suicide Prevention editorial, Julie Goldstein Grumet and David Jobes argue that while the Zero Suicide framework has driven meaningful reductions in suicide deaths, its “Treat” component — the use of evidence-based, suicide-specific treatments like DBT, CBT, and CAMS — remains inconsistently implemented across healthcare systems. The authors outline barriers to adoption (training gaps, malpractice fears, reimbursement structures) and offer six recommendations to close this evidence-to-practice gap, including expanded clinician training, reimbursement reform, and updated accreditation standards.

Authors: Julie Goldstein Grumet, Ph.D. and David A. Jobes, Ph.D. 

About the Author

David A. Jobes Ph.D. ABPP

David A. Jobes Ph.D. ABPP
David Jobes, PhD, ABPP, is the founder of CAMS-care, LLC. He began his career in 1987 in the Counseling Center of the Catholic University of America, where he developed a suicide risk assessment tool for college students that evolved into CAMS. Dr. Jobes is now a Professor of Psychology and Associate Director of Clinical Training at Catholic; he has trained thousands of mental health professionals in the United States and abroad in evidence-based assessment and treatment of suicide risk and the use of CAMS.